pegylated somatropin

DRUG2 trials

Sponsors

Changchun GeneScience Pharmaceutical Co., Ltd.

Conditions

Growth Hormone Deficiency

Phase 1

Crossover Study to Assess the Safety and Pharmacokinetic of Pegylated Somatropin(PEG Somatropin) in GHD Children

CompletedNCT01613573

Changchun GeneScience Pharmaceutical Co., Ltd.Growth Hormone Deficiency

Start: 2010-03-31End: 2010-11-30Updated: 2012-06-14

Phase 2

Efficiency and Safety Study of Pegylated Somatropin to Treat Growth Hormone Deficiency Children

CompletedNCT01342146

Changchun GeneScience Pharmaceutical Co., Ltd.Growth Hormone Deficiency

Start: 2006-05-31End: 2007-02-28Updated: 2017-07-31